Surmodics
Stock Forecast, Prediction & Price Target
Surmodics Financial Estimates
Surmodics Revenue Estimates
Surmodics EBITDA Estimates
Surmodics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 9/30/2022 | 9/30/2023 | 9/30/2024 | 9/30/2025 | 9/30/2026 | ||
Revenue
% change YoY
| $99.95M N/A | $132.58M 32.64% | $126.07M -4.90% | Avg: $137.70M Low: $137.66M High: $137.74M avg. 9.22% | Avg: $154.22M Low: $152.19M High: $155.54M avg. 11.99% | ||
Net Income
% change YoY
| $-27.27M N/A | $-1.53M 94.36% | $-11.54M -651.43% | Avg: $-6.47M Low: $-10.24M High: $982.17K avg. 43.90% | Avg: $1.81M Low: $-7.99M High: $11.50M avg. 128.09% | ||
EBITDA
% change YoY
| $-12.95M N/A | $15.15M 216.94% | $1.18M -92.15% | Avg: $5.61M Low: $5.61M High: $5.62M avg. 373.04% | Avg: $6.29M Low: $6.21M High: $6.34M avg. 11.99% | ||
EPS
% change YoY
| -$1.96 N/A | -$0.11 94.38% | -$0.82 -645.45% | Avg: -$0.45 Low: -$0.73 High: $0.07 avg. 45.12% | Avg: $0.13 Low: -$0.57 High: $0.82 avg. 127.77% | ||
Operating Expenses
% change YoY
| $51.09M N/A | $55.42M 8.46% | $98.69M 78.08% | Avg: $46.58M Low: $46.57M High: $46.59M avg. -52.80% | Avg: $52.17M Low: $51.48M High: $52.62M avg. 11.99% | ||
FAQ
What is Surmodics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 85.99% in 2025-2026.
We have gathered data from 2 analysts. Their low estimate is -10.24M, average is -6.47M and high is 982.17K.
What is Surmodics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 10.61% in 2025-2026.
We have gathered data from 2 analysts. Their low revenue estimate is $137.66M, average is $137.70M and high is $137.74M.
What is Surmodics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 86.44% in 2025-2026.
We have gathered data from 2 analysts. Their low earnings per share estimate is -$0.73, average is -$0.45 and high is $0.07.
What is the best performing analyst?
In the last twelve months analysts have been covering Surmodics stock. The most successful analyst is Brooks O’Neil.